en · de · es · pt
handling-notes.peptides4800.com › Faq › Peptide Identity And Research Origin — Deep Dive

Peptide Identity And Research Origin — Deep Dive

By Editorial Desk · published 2025-11-22 · last reviewed 2026-01-02 · Faq

If you have been reading about Epitalon and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-01-02. Where a claim depends on a specific study, the study is described rather than over-claimed.

Peptide Identity and Research Origin

The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.

Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.

Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.

Stability Handling and Quality Control

Reversed-phase high-performance liquid chromatography is the standard approach for assessing purity, usually with ultraviolet detection near 214 nm, where the peptide bond absorbs. Mass spectrometry, most often with electrospray ionization, confirms the molecular mass and helps reveal truncation or deletion byproducts. Amino acid analysis can verify composition, and counterion content is sometimes measured because peptides purified with trifluoroacetic acid retain variable amounts of that salt. Purity figures reported without a stated method and detection wavelength are difficult to interpret.

Material sold for research use varies widely in documented quality. A useful verification package includes a certificate of analysis that states peptide content rather than only net weight, the chromatographic method and column used, and a mass spectrum consistent with the expected mass. Independent testing by a third-party laboratory is occasionally reported. Statements of identity resting only on a supplier label provide little assurance, and the gap between nominal mass and actual peptide content can be substantial once counterions and residual water are counted.

Peptides of this size are generally stable as dry solids but degrade in solution over time. The principal routes are hydrolysis of the peptide backbone and oxidation, with hydrolysis favoured by elevated temperature and extreme pH. Aqueous solutions held at room temperature can show measurable loss of purity within days, while frozen aliquots are considerably more durable. Because the sequence contains neither cysteine nor methionine, oxidation is less of a concern than for many other peptides, but pH control during handling still matters.

Epitalon at a glance

PropertyValueNotes
Molecular formulaC14H22N4O9Synthetic tetrapeptide, four residues
Nominal massApproximately 390 DaFree peptide; salt forms differ
AppearanceWhite to off-white powderCommonly supplied lyophilised
Solubility classFreely soluble in waterAlso dissolves in aqueous buffer
Typical storage−20 °C, desiccatedCold packs used during transport

Background and Proposed Mechanism

Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.

Related pages on this site

Analytical Methods and Storage

Verification of research-grade material involves comparing a supplier chromatogram against an in-house reference, checking the observed mass against the calculated value, and where possible confirming residue order by tandem mass spectrometry or enzymatic peptide mapping. Purity claims should be read alongside the method used to obtain them, because detection wavelength and integration settings alter the result. Batch-specific data, rather than a generic grade statement, is the informative part of a certificate.

Identity and purity of epitalon samples are normally established by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, combined with mass spectrometry. The mass spectrum confirms the expected molecular ion and can reveal truncated or oxidised by-products. Amino acid analysis after acid hydrolysis verifies that the four residues are present in the expected ratio. Certificates typically report a purity figure taken from chromatographic peak area, expressed as a percentage of total integrated signal.

Epitalon Background And Identification

The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.

Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.

Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.

Epitalon in Research Literature and Handling

Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.

Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.

Supporting material

== See also == First 100 days of the second Trump presidency – Period from January to April 2025 List of executive actions by Donald Trump Lists of presidential trips made by Donald Trump (international trips) Second presidential transition of Donald Trump – Transfer of presidential power from Joe Biden to Donald Trump Timeline of the 2024 United States presidential election

==== Top leaders' comments ==== AQSIQ announced the revocation of all exemptions from inspection previously granted to dairy producers, who were asked to cease citing the privilege in their advertisements. The State Council ordered an overhaul of the dairy industry, and promised to provide free medical care to those affected. Formally, the State Council released its initial findings, and a top-level official apology of the incident both came on 21 September. Wen Jiabao apologised while visiting victims in hospitals.

=== Eukaryotic === Eukaryotic cells, encompassing animals, plants, fungi, and protists, are characterized by their complex cellular structures, including a true nucleus and membrane-bound organelles. Sterols, a subgroup of steroids, play key roles in maintaining membrane fluidity, supporting cell signaling, and enhancing stress tolerance. These compounds are integral to eukaryotic membranes, where they contribute to membrane integrity and functionality. During eukaryogenesis—the evolutionary process that gave rise to modern eukaryotic cells—steroids likely enabled the endosymbiotic acquisition of mitochondria.

Eva Megyar as Katherine, (season 1), Hermione's grandmother Monica Lacy as Janis Copeland (season 1), an agent of the Department of Statistical Anomalies (DOSA) Josh Gates as an archaeologist and former colleague of Connor's (season 2) Jeremy Swift as a flamboyant genie (season 2), who can grant wishes to anyone who explicitly states "I wish" if he is released and unbound from his bottle Flula Borg and Britta Boehlke, respectively, as Gunther and Hilda (season 2), two hosts of a popular cooking show who are secretly a magically-charged, cannibalistic Hansel and Gretel Oliver Dench as Robert/"The Red Rock", a kindly scientist and Lysa's love interest who secretly uses a strength-boosting artifact to fight crime as a superhero, unaware it turns those around him into criminals to fight Claudia Summers as Jill Pascal (season 2), Lysa's late mother Evan Milton as Luc Pascal (season 2), Lysa's late father Holly Donovan as Amy Scott (season 2) Lindy Booth (season 2) as Cassandra Cillian, one of the Librarians from the Portland Annex who specializes in mathematics and practices magic. She was introduced in The Librarians and officially joined the Library at the same time as Jacob Stone.

Sources: en.wikipedia.org

Supporting material

All of the opioids can cause side effects. Adverse reactions in patients taking opioids include reinforcement disorders, nausea and vomiting, drowsiness, itching, dry mouth, dizziness, and constipation. In older adults, opioid use is associated with increased adverse effects such as "sedation, nausea, vomiting, constipation, urinary retention, and falls". As a result, older adults taking opioids are at greater risk for injury. Opioids do not cause any specific organ toxicity, unlike many other drugs, such as aspirin and paracetamol. They are not associated with upper gastrointestinal bleeding and kidney toxicity. Prescription of opioids for acute low back pain and management of osteoarthritis seem to have long-term adverse effects

== Discovery and ownership background == On 1 November 2005, Cambridge Antibody Technology (CAT) announced it was acquiring two anti-CD22 immunotoxin products from Genencor, namely GCR-3888 and GCR-8015. Genencor is the biotechnology division of Danisco and the acquisition meant CAT would hire certain former Genencor key employees to be responsible for the development of the programmes. GCR-3888 and GCR-8015 were discovered and initially developed by the National Cancer Institute, which is part of the U.S. National Institutes of Health. Genencor licensed the candidates for hematological malignancies and entered into a Cooperative Research and Development Agreement (CRADA) with the NIH, which will now be continued by CAT. Under the original license agreement with the NIH, CAT gained the rights to a portfolio of intellectual property associated with the programs and would pay future royalties to the NIH. CAT intended to file an Investigational New Drug (IND) application for GCR-8015 in various CD22 positive B-cell malignancies, including Non-Hodgkin lymphoma and chronic lymphocytic leukemia, following a period of manufacturing development which is expected to be complete by the end of 2006 and to support the NCI's ongoing development of GCR-3888 in Hairy cell leukemia (HCL) and pediatric acute lymphoblastic leukemia (pALL). CAT-8015 exhibited a greater affinity for CD22 than its predecessor, CAT-3888 and CAT's language such as "CAT will support the NCI's ongoing development of CAT-3888..." suggested at the time that their focus was on the second generation candidate.

In 2018 Stonewall described UK transgender healthcare as having "significant barriers to accessing treatment, including waiting times that stretch into years, far exceeding the maximums set by law for NHS patients". Patients have the legal right to begin treatment within 18 weeks of referral by their GP, however the average wait for patients to gender identity clinics was 18 months in 2020 with over 13,000 people on the waiting list for appointments at gender identity clinics. As of May 2024, prescription of puberty blockers to new patients under 18 for the treatment of gender dysphoria is banned for both private medical practices (by a law in parliament in May) and the official state healthcare National Health Service (NHS) which stopped their use earlier, in the aftermath of the Cass Review except for use in clinical research trials. Previously, on 30 June 2020, the NHS changed its website, replacing the statement that puberty blockers were "fully reversible" and that "treatment can usually be stopped at any time"; with "little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria. The Bell v Tavistock decision by the High Court of Justice for England and Wales ruled children under 16 were not competent to give informed consent to puberty blockers, but this was overturned by the Court of Appeal in September 2021. In 2022, the British Medical Association opposed restrictions on puberty blockers, and the NHS restricted their use for children under 16 years of age to centrally administered clinical research.

Chemical: In addition to dead organic matter, the earthworm also ingests any other soil particles that are small enough, including sand grains up to 1⁄20 inch (1.3 mm), into its gizzard, wherein those minute fragments of grit (gastroliths) grind everything into a fine paste which is then digested in the intestine, increased surface area favouring microbial colonization and enzymatic action. When the worm excretes this paste in the form of casts, deposited on the surface or deeper in the soil, carbon, nitrogen and phosphorus are increased compared to the bulk soil and nutrients are changed to a plant-available form, increasing locally soil fertility. In conditions where humus is plentiful, the weight of casts produced may be greater than 4.5 kilograms (9.9 lb) per worm per year. Physical: The earthworm's burrowing creates a multitude of channels through the soil and is of great value in maintaining the soil structure, enabling processes of aeration and drainage. Permaculture co-founder Bill Mollison points out that by sliding in their tunnels, earthworms "act as an innumerable army of pistons pumping air in and out of the soils on a 24-hour cycle (more rapidly at night)". Thus, the earthworm not only creates passages for air and water to traverse the soil, i.e. increases soil porosity, but also as a soil engineer its bioturbation activities modify the vital organic component that makes a soil healthy. Earthworms promote the formation of nutrient-rich casts that have high soil aggregation (good soil structure) and soil fertility and quality.

Chain brake A chain brake activator is located forward of the upper handle and is activated by a kickback event. When triggered, it tensions a band around the clutch drum, stopping the chain within milliseconds. A chain catcher is located between the saw body and the clutch cover. In most cases, it resembles a hook made of aluminum. It is used to stop the chain when it derails from the bar and shortens the length of the chain. When derailing, the chain swings from underneath the saw towards the operator. This prevents the chain from hitting the operator, which hits the rear handle guard instead. A rear handle guard protects the hand of the operator when the chain derails. Some chains have safety links, as on micro chisel saws. These links keep the saw close to the gap between two cutting links and lift the chain when the space at the safety link is full with saw chips, which lifts the chain and lets it cut slower. Nonprofessional chains have less aggressive teeth, by having shallower depth gauges.

Sources: en.wikipedia.org

Supporting material

=== Alleged conflict of interest === In September 2026, a Powerus delegation met General Asim Munir and a MoU was signed between the Pakistan Army and the Trump-family backed drone maker while the company was due to merge with Aureus Greenway Holdings linked to Eric Trump and Donald Trump Jr. However, Andrew Fox, Powerus' founder, denied that "the company's growth was linked to the involvement of Trump's sons."

=== Nonsurgical === Prevention of movement between the layers allows the tentative initial bond of fibrin to be reinforced by wound healing with a thin, strong, layer of scar. Avoiding certain positions for certain surgeries may have an effect. (In abdominoplasty, sitting upright with the knees bent and hips flexed will cause pressure across the lower abdomen and a tendency to seroma formation. The patient is best to stand or at least be semirecumbent). External pressure may help in immobilization, but also is thought to reduce the tendency of the fluid to leak out of vessels by increasing the backpressure on those fluid sources. Following breast augmentation or double mastectomy, binding the chest may be recommended for several weeks to minimize the risk of seromas.

=== South Korea === TPMS became obligatory for every vehicle under 3.5t sold after 2013. Later in 2015, every vehicle had to have TPMS regardless of its size. In 2011, Hyundai Mobis successfully developed the TPMS and first applied it in the Veloster. The resulting sensor uses about 30% less power than previous products, which allows for a smaller battery and reduces the sensor's weight by more than 10%.

Since the 2000s, cursive writing has been de-emphasized in public education. As a result, Generation Z are less likely to read and write in cursive. Some states introduced legislation to teach it in their jurisdiction, partly because some 80% of historical records and documents of the United States was written by hand in cursive. The percentage of American fourth-graders proficient in reading declined during the late 2010s, according to the National Assessment of Educational Progress (NAEP). There have been numerous reports in the 2010s on how U.S. students were falling behind their international counterparts in the STEM subjects, especially those from (East) Asia. For example, American schoolchildren put up a mediocre performance on the Program for International Student Assessment (PISA), administered to fifteen-year-old students around the world on reading comprehension, mathematics, and science, falling in the middle of the pack in 2015. In fact, reading scores dropped for all ethnic groups except Asians in the late 2010s, according to the NAEP. Nevertheless, American students ranked above the OECD average in science and computer literacy, as of 2021. As of 2024, NAEP data showed that the reading and mathematical skills of American schoolchildren on average still had not recovered from the COVID-19 pandemic. Furthermore, while the strongest students had regained lost grounds, the weakest continued to fall behind. An emphasis on rote memorization and speed gives as many as one in three students age five and up mathematical anxiety.

== Operations == Icon provides outsourced drug development, clinical research, and consulting services for pharmaceutical, biotechnology, medical device, and government organizations. The company supports therapies throughout the development lifecycle, from early-stage research and clinical trial design through Phase I–IV clinical trials and commercialization. Its services include clinical trial management, laboratory and imaging services, patient recruitment, data analysis, and regulatory and market access consulting across a range of therapeutic areas.

Sources: en.wikipedia.org

Frequently asked questions

Is epitalon the same as epithalamin?

No. Epithalamin is a heterogeneous peptide fraction obtained from pineal gland extract and contains many components. Epitalon is a single synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. Researchers synthesised the shorter peptide while attempting to identify active sequences within the extract.

Does epitalon occur naturally in the human body?

No endogenous peptide with this exact sequence has been described as a circulating hormone or signalling molecule. The tetrapeptide was designed as a synthetic analogue based on fragments observed in pineal preparations. Any activity discussed in the literature therefore refers to administered material rather than to a natural pool of the compound.

What regulatory category does epitalon fall into?

It is not an approved medicine in major jurisdictions and does not appear in the major pharmacopoeias. Material is usually distributed as a research chemical or laboratory reagent. Such labelling places handling responsibility on the purchaser and does not indicate that a regulatory body has reviewed the substance.

How should lyophilized epitalon be stored?

The powder is normally kept at −20 °C or below in a sealed, moisture-protected container. Letting the vial reach room temperature before opening helps prevent condensation on the contents.

Network